| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 678637 | Benzoic acid, 4-[[(3,6-dioxo-1,4-cyclohexadienyl)methyl]amino]-, tert-butyl ester | 0.00397405528023193 | 0.29131537 |
| NSC 685687 | 1,2,5,6,9-Pentaazadicylopent[a,b]indene-3,4(2H,5H)-dione,2,5-diphenyl- | 0.00397405528023193 | 0.35608514 |
| NSC 687330 | Adenosine, 2'-amino-2'-deoxy-3',5'- O-[1,1,3,3-tetrakis(1-methylethyl)-1,3-disiloxanediyl]- (9CI) | 0.00397405528023193 | 0.39121745 |
| NSC 703141 | Null | 0.00397405528023193 | 0.34152707 |
| NSC 725191 | 1,6-bis[(1S,4R,5R,8R,12R,13S)-1,5-dimethyl-10-(trifluorometh yl)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexade c-9-en-9-yl]-3-hexene-1,6-diol | 0.00397405528023193 | 0.36370602 |
| NSC 736164 | pyrazoline derivative | 0.00397405528023193 | 0.55393749 |
| NSC 740385 | 7-fluoro-2-benzoyl-3-trifluoromethylquioxaline 1,4-dioxide | 0.00397405528023193 | 0.40252899 |
| NSC 763646 | (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole | 0.00397405528023193 | 0.31875723 |
| NSC 88054 | Null | 0.00397405528023193 | 0.36597254 |
| NSC 96932 | 3,3'-Diethyl-9-methylthiacarbocyanine iodide | 0.00397405528023193 | 0.33719826 |